Posts Categorized: MS News

  Source MS Society: A study published in the journal Nature this week has found that an existing treatment, used for another health condition, may have the potential to repair damaged myelin. Read all about it here!

Source The Lancet: A new two-part Lancet Series on stem cells outlines exciting new advances in the treatment of multiple sclerosis and severe epidermolysis bullosa, a rare but devastating genetic skin disease. In the first Series paper, Professor Neil Scolding and colleagues, outline the latest challenges and exciting potential for stem cell treatment of multiple… Read more »

For the next meet up the plan is to go Bowling at Oxford Bowlplex and have something to eat. The choice of dates are as follows:- Wednesday 16th Oct evening Thursday 17th or Sunday 27th afternoon or evening The Bowling will cost £6 and will need to be paid when date is decided.  

  Source BBC The number of people diagnosed with multiple sclerosis in the UK is falling while the number of those living with the disease is growing, research shows. (Note: This is why it is so important to continue to support your local MS Therapy Centre who provide long term care and support for people… Read more »

Source MS Society: Results of a new study into finding the genes that may increase a person’s likelihood of developing MS have been published today (30th Sept) in the journal Nature Genetics.  Read more here!

Multiple sclerosis cases hit 2.3m worldwide Source Trade Arabia: The number of people living with multiple sclerosis around the world has increased by 10 per cent in the past five years to 2.3 million, according to the most extensive survey of the disease to date.  Read more here.

Source BBC The number of people diagnosed with multiple sclerosis in the UK is falling while the number of those living with the disease is growing, research shows. (Note: This is why it is so important to continue to support your local MS Therapy Centre who provide long term care and support for people with… Read more »

Source NICE: Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis.  Read more here.

Source MS Society: The DWP has announced it will delay, until 28 October 2013, the roll out of face to face benefits assessments for people moving from DLA to Personal Independence Payments. The MS Society is calling for an end to the 20 metre rule for the enhanced rate mobility component of the benefit.  Read more here.

The MS Society’s Short Breaks and Activities (SBA) Fund provides financial support to people affected by MS. The fund can consider grants for people with MS and their carers to help them access a broad range of short breaks and activities. MS Society  Short Breaks booklets available at the centre, for more info go to… Read more »